Latest Stories
Unpacking Q4 Earnings: Artivion (NYSE:AORT) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including Artivion (NYSE:AORT) and its peers.
ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings?
Even during a down period for the markets, ANI Pharmaceuticals has gone against the grain, climbing to $68.06. Its shares have yielded a 16.1% return over the last six months, beating the S&P 500 by 23%. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Q4 Earnings Roundup: SolarEdge (NASDAQ:SEDG) And The Rest Of The Renewable Energy Segment
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at SolarEdge (NASDAQ:SEDG) and its peers.
3 Reasons SPHR is Risky and 1 Stock to Buy Instead
Sphere Entertainment has gotten torched over the last six months - since October 2024, its stock price has dropped 44.8% to $26.99 per share. This might have investors contemplating their next move.
2 Reasons to Like AGL and 1 to Stay Skeptical
What a fantastic six months it’s been for agilon health. Shares of the company have skyrocketed 65.7%, hitting $5.50. This run-up might have investors contemplating their next move.
U.S. Physical Therapy (USPH): Buy, Sell, or Hold Post Q4 Earnings?
Although the S&P 500 is down 6.9% over the past six months, U.S. Physical Therapy’s stock price has fallen further to $70.65, losing shareholders 14.1% of their capital. This might have investors contemplating their next move.
3 Reasons to Sell MGM and 1 Stock to Buy Instead
What a brutal six months it’s been for MGM Resorts. The stock has dropped 23.9% and now trades at $29.97, rattling many shareholders. This may have investors wondering how to approach the situation.
Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - specialty stocks fared in Q4, starting with Teleflex (NYSE:TFX).
3 Reasons to Avoid SOUN and 1 Stock to Buy Instead
SoundHound AI has been on fire lately. In the past six months alone, the company’s stock price has rocketed 54.8%, reaching $8.22 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Lowe's (LOW): Buy, Sell, or Hold Post Q4 Earnings?
Lowe's has gotten torched over the last six months - since October 2024, its stock price has dropped 20% to $225.44 per share. This might have investors contemplating their next move.